Healthcare AI investors focused on Pharma / Therapeutics
Venture firms, family offices, accelerators, and corporate VCs with explicit thesis exposure to Pharma / Therapeutics within healthcare AI. Includes lead investors, follow-on participants, and active angels.
The therapeutics sector focuses on the scientific research, clinical development, and commercialization of chemical or biological compounds used to treat diseases. Venture investment in this space is heavily milestone-driven, guiding novel drugs from early pre-clinical laboratory research through rigorous, multi-phase human clinical trials to ultimate regulatory approval.
339
investors match
Within Pharma / Therapeutics: top investment stages
Apricot Capital
VC
T3
Biotech
Medical Devices / MedTech
ARCH Venture Partners
VC
AI
T1
AI/ML in Healthcare
Biotech
Arsenal Capital Partners
PE
T3
Life Sciences Tools
Pharma / Therapeutics
Astellas Venture Management
Corporate VC
T3
Biotech
Pharma / Therapeutics
AstraZeneca Strategic Partnering
Corporate VC
AI
T3
AI/ML in Healthcare
Biotech
Atinum Investment
VC
AI
T3
Biotech
Health IT / Healthcare Software
Aurus Capital
VC
T2
Biotech
Medical Devices / MedTech
Australian Future Fund
PE
T3
Digital Health
Pharma / Therapeutics
Ayala Ventures
Corporate VC
T2
Care Delivery / Tech-Enabled Services
Pharma / Therapeutics
B-Flexion Life Sciences
VC
T3
Life Sciences Tools
Pharma / Therapeutics
Balyasny Asset Management
PE
T3
Biotech
Pharma / Therapeutics
Bamboo Capital Partners
VC
T2
Digital Health
Health IT / Healthcare Software
Bayhelix Group
Angel Network
T3
Biotech
Medical Devices / MedTech
BioMedPartners
VC
T3
Biotech
Medical Devices / MedTech
BIRAD
VC
AI
T3
Biotech
Pharma / Therapeutics